Arkolith/Insider Trading/BCTX/Form 4

Williams William V.

President, CEO, DirectorBriaCell Therapeutics Corp. (BCTX) · full profile →Form 4 · filed Dec 28, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2022Buy(P)3K$1.94$5K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-036643) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML